These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic and dietary factors in idiopathic calcium nephrolithiasis. What do we have, what do we need? Baggio B J Nephrol; 1999; 12(6):371-4. PubMed ID: 10626826 [TBL] [Abstract][Full Text] [Related]
3. [Vitamin C and stone risk. Review of the literature]. Traxer O; Pearle MS; Gattegno B; Thibault P Prog Urol; 2003 Dec; 13(6):1290-4. PubMed ID: 15000301 [TBL] [Abstract][Full Text] [Related]
4. Diet and kidney stones. Am Fam Physician; 1984 Apr; 29(4):110, 112. PubMed ID: 6720487 [No Abstract] [Full Text] [Related]
5. [Can the administration of large doses of vitamin C have a harmful effect?]. Wróblewski K Pol Merkur Lekarski; 2005 Oct; 19(112):600-3. PubMed ID: 16379336 [TBL] [Abstract][Full Text] [Related]
6. Nephrolithiasis associated with the ketogenic diet. Kielb S; Koo HP; Bloom DA; Faerber GJ J Urol; 2000 Aug; 164(2):464-6. PubMed ID: 10893623 [TBL] [Abstract][Full Text] [Related]
10. Dietary intake as a risk factor for pancreatic cancer in Japan: high cholesterol and low vitamin C diet. Takeyama Y J Gastroenterol; 2005 Mar; 40(3):324-5. PubMed ID: 15830299 [No Abstract] [Full Text] [Related]
11. Letter: High doses of ascorbic acid. Tan SG; Cunliffe WJ Br J Dermatol; 1975 Dec; 93(6):731. PubMed ID: 1240766 [No Abstract] [Full Text] [Related]
14. [The change of human Na+/dicarboxylate co-transporter 1 expression in the kidney and its relationship with pathogenesis of nephrolithiasis]. He Y; Chen X; Yu Z Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1066-9. PubMed ID: 11758258 [TBL] [Abstract][Full Text] [Related]
15. Ascorbic acid is an abettor in calcium urolithiasis: an experimental study. Singh PP; Kiran R; Pendse AK; Gosh R; Surana SS Scanning Microsc; 1993 Sep; 7(3):1041-7; discussion 1047-8. PubMed ID: 8146605 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. Curhan GC; Willett WC; Rimm EB; Stampfer MJ J Urol; 1996 Jun; 155(6):1847-51. PubMed ID: 8618271 [TBL] [Abstract][Full Text] [Related]
17. Safety considerations with high ascorbic acid dosage. Barness LA Ann N Y Acad Sci; 1975 Sep; 258():523-8. PubMed ID: 946 [No Abstract] [Full Text] [Related]
18. Hyperuricosuria and calcium nephrolithiasis. Coe FL; Parks JH Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958 [No Abstract] [Full Text] [Related]
19. [Observations on the clinical aspects of nephrolithiasis]. Alken CE Urologe; 1966 Jul; 5(4):161. PubMed ID: 5995235 [No Abstract] [Full Text] [Related]
20. [Purine metabolism and recurrent nephrolithiasis]. Müller MM Med Lab (Stuttg); 1981; 34(3):69-76. PubMed ID: 7231351 [No Abstract] [Full Text] [Related] [Next] [New Search]